Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07349589
PHASE1
Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers
Sponsor: Daewon Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
Official title: A Randomized, Open-label, Single-dose, Parallel-design, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2026-02-01
Completion Date
2026-12-01
Last Updated
2026-01-20
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DW5524
DW5524
DRUG
DW5524-A
DW5524-A
Locations (1)
Chungbuk National University Hospital
Cheongju-si, South Korea